Jpmorgan Chase & Co - Apr 30, 2025 SCHEDULE 13G/A Report for KEROS THERAPEUTICS, INC. Common Stock, $0.0001 par value per share (KROS)

Filing Manager: JPMORGAN CHASE & CO
Reporting Manager: JPMORGAN CHASE & CO.
Security: KEROS THERAPEUTICS, INC. Common Stock, $0.0001 par value per share
Symbol: KROS
Disclosed Ownership: 114K shares
Ownership: 0.2%
Form type: SCHEDULE 13G/A
Date filed: 5/5/2025, 02:03 PM
Date of event: Apr 30, 2025
Previous filing: May 2, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
JPMORGAN CHASE & CO.	0.2%	114K	114K	0	Rachel Tsvaygoft	Vice President